BREA, Calif. - Envista Holdings Corporation (NYSE: NYSE:NVST), a major player in the dental products industry, has begun the process to select a new Chief Executive Officer, the company announced today. The current President and CEO, Amir Aghdaei, will continue to lead the company until a successor is appointed.
The Board of Directors has established a search committee and engaged an executive search firm to identify potential external candidates to helm Envista's next phase. This search is anticipated to conclude within the year. Aghdaei, who has been at the forefront of Envista for nearly a decade, expressed his commitment to the company's ongoing transformation and its strategic long-term goals, including growth acceleration, margin expansion, and portfolio transformation.
Board Chair Scott Huennekens acknowledged Aghdaei's significant contributions, especially during the company's spinoff from Danaher (NYSE:DHR) and the challenges posed by the global pandemic. He emphasized the importance of a seamless and orderly transition to a new leader who will continue to drive value for customers, employees, and shareholders.
Envista, known for its portfolio of over 30 trusted dental brands such as Nobel Biocare, Ormco, DEXIS, and Kerr, partners with dental professionals to enhance patient care. The company offers a wide range of products and services, including dental implants, orthodontics, and digital imaging technologies, addressing the clinical needs of dentists for diagnosis, treatment, and cosmetic enhancements.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.